MyAverix Finance
US · Healthcare
Xebra Brands Ltd (XBRAF)
Drug Manufacturers - Specialty & Generic
Xebra Brands Ltd (XBRAF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for XBRAF
Xebra Brands Ltd (XBRAF) — FAQ
What is XBRAF's P/E ratio?
The price-to-earnings (P/E) ratio for Xebra Brands Ltd (XBRAF) is 18.00 (data as of 2026-05-23).
Does Xebra Brands Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Xebra Brands Ltd (XBRAF). Check the MyAverix Finance app for the latest dividend data.
What sector is Xebra Brands Ltd in?
Xebra Brands Ltd (XBRAF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is XBRAF listed on?
XBRAF is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.